Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 19:8:644295.
doi: 10.3389/fmed.2021.644295. eCollection 2021.

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin

Hayder M Al-Kuraishy  1 , Ali I Al-Gareeb  1 , M Alblihed  2 , Natália Cruz-Martins  3   4   5 , Gaber El-Saber Batiha  6
Affiliations

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin

Hayder M Al-Kuraishy et al. Front Med (Lausanne). .

Abstract

Background: Coronavirus disease 19 (COVID-19) is regarded as an independent risk factor for acute ischemic stroke (AIS) due to the induction of endothelial dysfunction, coagulopathy, cytokine storm, and plaque instability. Method: In this retrospective cohort study, a total of 42 COVID-19 patients with type 2 diabetes mellitus (T2DM) who presented with AIS within 1 week of displaying COVID-19 symptoms were recruited. According to the current anti-DM pharmacotherapy, patients were divided into two groups: a Metformin group of T2DM patients with COVID-19 and AIS on metformin therapy (850 mg, 3 times daily (n = 22), and a Non-metformin group of T2DM patients with COVID-19 and AIS under another anti-DM pharmacotherapy like glibenclamide and pioglitazone (n = 20). Anthropometric, biochemical, and radiological data were evaluated. Results: Ferritin serum level was lower in metformin-treated patients compared to non-metformin treated patients (365.93 ± 17.41 vs. 475.92 ± 22.78 ng/mL, p = 0.0001). CRP, LDH, and D-dimer serum levels were also lowered in metformin-treated patients compared to non-metformin treated patients (p = 0.0001). In addition, lung CT scan scores of COVID-19 patients was 30.62 ± 10.64 for metformin and 36.31 ± 5.03 for non-metformin treated patients. Conclusion: Metformin therapy in T2DM patients was linked to a lower risk of AIS during COVID-19. Further studies are needed to observe the link between AIS in COVID-19 diabetic patients and metformin therapy.

Keywords: COVID-19; SARS-CoV-2; acute ischaemic stroke; diabates mellitus; metformin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Consort-flow chart of the study.
Figure 2
Figure 2
Lung CT scan score in T2DM patients with COVID-19 on metformin therapy.
Figure 3
Figure 3
Neutrophil: lymphocyte ratio (NLR) in T2DM patients with COVID-19 and AIS compared with the controls. *P = 0.0001 compared to metformin and non-metformin treated patients.
Figure 4
Figure 4
Stroke risk ratio (SRR) in T2DM patients with COVID-19 and acute ischemic stroke compared with the controls. *P = 0.0001 compared to metformin and non-metformin treated patients. #P = 0.01 compared non-metformin treated patients.
See this image and copyright information in PMC

References

    1. Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. . COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduc Target Ther. (2020) 5:1–8. 10.1038/s41392-020-00243-2 - DOI - PMC - PubMed
    1. Al-Kuraishy HM, Al-Naimi MS, Lungnier CM, Al-Gareeb AI. Macrolides and COVID-19: an optimum premise. Biomed Biotechnol Res J. (2020) 4:189. 10.4103/bbrj.bbrj_103_20 - DOI
    1. Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, et al. . Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry. Stroke. (2020) 51:e254–8. 10.1161/STROKEAHA.120.031208 - DOI - PMC - PubMed
    1. Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. . COVID-19 is an independent risk factor for acute ischemic stroke. Am J Neuroradiol. (2020) 41:1361–4. 10.3174/ajnr.A6650 - DOI - PMC - PubMed
    1. Tan YK, Goh C, Leow AS, Tambyah PA, Ang A, Yap ES, et al. . COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thromb. (2020) 50:587–95. 10.1007/s11239-020-02228-y - DOI - PMC - PubMed